Ruud H. Deurenberg

, Eric Nulens, Havard Valvatne, Silvie Sebastian, Christel Driessen, Jos Craeghs, Els De Brauwer, Bernhard Heising, Yvette J. Kraat, Joachim Riebe, Frans S. Stals, Thera A. Trienekens, Jacques Scheres, Alexander W. Friedrich, Frank H. Van Tiel, Patrick S. Beisser, and Ellen E. Stobberingh
Author affiliations: University Hospital Maastricht, Maastricht, the Netherlands (R.H. Deurenberg, H. Valvatne, S. Sebastian, C. Driessen, J. Scheres, F.H. van Tiel, P.S. Beisser, E.E. Stobberingh); General Hospital Sint-Jan, Brugge, Belgium (E. Nulens); General Hospital Vesalius, Tongeren, Belgium (J. Craeghs); Atrium Medical Center, Heerlen, the Netherlands (E. De Brauwer); General Hospital Düren, Düren, Germany (B. Heising); Orbis Medical and Care Center, Sittard, the Netherlands (Y.J. Kraat); Laboratory Aachen, Aachen, Germany (J. Riebe); Laurentius Hospital, Roermond, the Netherlands (F.S. Stals); VieCuri Medical Center, Venlo, the Netherlands (T.A. Trienekens); University of Münster, Münster, Germany (A.W. Friedrich)
Main Article
Table 4
Suggested cross-border dissemination of the major MRSA clones in the Euregio Meuse-Rhin region, July 2005–April 2006*
| MRSA clone |
Previously observed in/possible dissemination from |
| ST5-MRSA-II |
Belgium, Germany |
| ST5-MRSA-IV |
Belgium |
| ST8-MRSA-IV |
Belgium, Germany, the Netherlands |
| ST22-MRSA-IV |
Belgium, Germany |
| ST30-MRSA-IV |
Belgium, Germany |
| ST36-MRSA-II |
Belgium |
| ST45-MRSA-IV |
Belgium, Germany, the Netherlands |
Main Article
Top of Page